Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects

Autor: Jan Oscarsson, Remi A. Momo, Li-Ming Gan, Peter J. Greasley, Erika Rehnström, Regina Fritsche-Danielson, Sara Svedlund, Helena U. Westergren, Juuso I. Blomster, Karin Wåhlander
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Time Factors
Endocrinology
Diabetes and Metabolism

Coronary Artery Disease
030204 cardiovascular system & hematology
Coronary artery disease
0302 clinical medicine
Risk Factors
Medicine
Glucose homeostasis
Angiogenic Proteins
Endothelial dysfunction
Original Investigation
Outcome
education.field_of_study
Middle Aged
Vasodilation
Cardiology
Female
Inflammation Mediators
Growth factors
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
Population
Hyperemia
Disease-Free Survival
Angina Pectoris
Prediabetic State
03 medical and health sciences
Insulin resistance
Diabetes mellitus
Internal medicine
Humans
education
Aged
Proportional Hazards Models
Angiology
Chi-Square Distribution
business.industry
Vascular Endothelial Growth Factor D
Endothelial function
medicine.disease
030104 developmental biology
Gene Expression Regulation
Multivariate Analysis
Linear Models
Endothelium
Vascular

Non-obstructive coronary artery disease
business
Biomarkers
Zdroj: Cardiovascular Diabetology
ISSN: 1475-2840
DOI: 10.1186/s12933-016-0353-1
Popis: Background Patients with angina-like symptoms without myocardial perfusion scintigram (MPS)-verified abnormality may still be at risk for cardiovascular events. We hypothesized that insulin resistance could play a role in this population even without diagnosed diabetes. We further explored physiological and blood biomarkers, as well as global gene expression patterns that could be closely related to impaired glucose homeostasis to deepen our mechanistic understanding. Methods A total of 365 non-diabetic patients with suspected myocardial ischemia referred to MPS were enrolled and followed up regarding event-free survival with a median time of 5.1 years. All patients underwent endothelial function assessment by reactive hyperemic index (RHI) using EndoPAT and extensive biomarker analysis. Whole blood global gene expression pathway analysis was performed in a subset of patients. Results Homeostasis model assessment of insulin resistance (HOMA-IR) added independent prognostic value in patients without myocardial perfusion defects. In a multivariable analysis, HOMA-IR was inversely associated with low RHI. Furthermore, elevated HOMA-IR was associated with decreased levels of vascular endothelial growth factor D, stem cell factor and endocan as well as to increased level of interleukin-6. Global gene expression pathway analysis of whole blood cells showed that high HOMA-IR and impaired endothelial function were associated with upregulated pro-inflammatory pathways and down-regulated eukaryotic initiation factor-2 pathway. Conclusions Insulin resistance measured by HOMA-IR is associated with endothelial dysfunction and confers independent prognostic information in non-diabetic patients with chest pain without myocardial perfusion defects. Increased systemic pro-inflammatory state and decreased levels of pro-angiogenic vascular growth factors may be important underlying molecular mechanisms.
Databáze: OpenAIRE